Phibro Animal Health Corporation (PAHC)

Market Cap	1.28B
Revenue (ttm)	1.19B
Net Income (ttm)	31.79M
Shares Out	40.53M
EPS (ttm)	0.78
PE Ratio	39.84
Forward PE	12.89
Dividend	$0.48 (1.54%)
Ex-Dividend Date	Jun 4, 2025

Volume	460,094
Open	30.48
Previous Close	30.12
Day's Range	30.20 - 31.53
52-Week Range	16.16 - 31.48
Beta	0.74
Analysts	Hold
Price Target	24.50 (-22.17%)
Earnings Date	Aug 27, 2025

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Apr 11, 2014
• Employees: 1,940
• Stock Exchange: NASDAQ
• Ticker Symbol: PAHC
• Website: https://www.pahc.com

Financial Performance

In 2024, Phibro Animal Health's revenue was $1.02 billion, an increase of 4.07% compared to the previous year's $977.89 million. Earnings were $2.42 million, a decrease of -92.59%.

Analyst Summary

According to 4 analysts, the average rating for PAHC stock is "Hold." The 12-month stock price target is $24.5, which is a decrease of -22.17% from the latest price.

Price Target

$24.5

(-22.17% downside)

Analyst Consensus: Hold